Cerebral venous thrombosis secondary to essential thrombocythemia;Thrombose veineuse cérébrale secondaire à une thrombocytémie essentielle

Revue Neurologique

Volumn 163, Issue 5, 2007, Pages 596-598

  Messouak, O ^a   Alaoui Faris, M ^b   Benabdejlil, M ^b   Tizniti, S ^a   Belahsen, F ^a  

^a HASSAN II UNIVERSITY HOSPITAL   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

Author keywords

Cerebral venous thrombosis; Essential thrombocythemia; Myeloproliferative syndrome; Thrombocytosis

Indexed keywords

ACETAZOLAMIDE; ALLOPURINOL; ANALGESIC AGENT; ANTICOAGULANT AGENT; HYDROXYUREA;

ABDOMINAL RADIOGRAPHY; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CYTOREDUCTIVE SURGERY; DISEASE COURSE; DISEASE DURATION; DRUG INDICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTRACRANIAL HYPERTENSION; MYELOPROLIFERATIVE DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PAPILLEDEMA; PHYSICAL EXAMINATION; SUPERIOR SAGITTAL SINUS; THROMBOCYTHEMIA; TREATMENT OUTCOME; VEIN THROMBOSIS; VISUAL ACUITY;

EID: 34249889981     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90467-1     Document Type: Article

References (17)

1. AMERI A, BOUSSER Mg, CHIRAS J, ROUGEMONT D (1992). Thromboses veineuses cérébrales - Éditions Techniques-Encycl Med Chir (Paris-France). Neurologie, 17-046-R-10 : 11p.
2. BARBUI T, FINAZZI G, DUPUY E, KILADJIAN JJ, BRIÈRE J. (1996). Treatment strategies in essential thrombocythaemia: a critical appraisal of various experiences in different center. Leukaemia and Lymphoma, 22: 149-160.
3. BOUSSER MG. (1991) Thromboses veineuses cérébrales à propos de 76 cas. Journal des maladies vasculaires, (Paris) 16 : 249-255.
4. BRIERE J. (2001). La thrombocytemie essentielle. Hématologie, 7 : 221-230.
5. BRIÈRE J, GUILMIN F. (2001). Management of patients wwith essential thrombocythemia: current concepts and perspectives. Pathol Biol, 49: 1-83.
6. CORTELAZZO S, VIERO P, PINAZZI G, D'EMILIO A, RODEGHIERO E, BARBUI T. (1990). Incidence and risk factors for thrombotic complications in historical cohort of 100 patients with essential thrombocythaemia. J Clin Oncol, 8: 556-562.
7. CORTELAZZO S, FINAZZI G, RUGGERI M. (1995). Hydroxyurea in the treatment of patients with essential thrombocythaemia at high risk of thrombosis: a prospective randomized trial. N Engl J Med, 332: 1132-1136.
8. GISSLINGER H, RODEGHIERO F, RUGGERI M, HELS-VAHIDI F, MANNHALTER C, P APAGIANNOPOULOS M. (1999). Homocysteine levels in polycythemia vera and essential thrombocythaemia. Br J Haematol, 105: 551-555.
9. GRIESSHAMMER M, BANGERTER M, VAN VLIET HH, MICHIELS JJ. (1997). Aspirin in essential thrombocythaemia: status quo and quovadis. Semin Thromb Hemost, 23: 371-377.
10. JAFFE ES. (2001). World Health Organization Classification of Tumors. Pathology and genetics of tumors of haematopoitic and lymphoid tissues. IARC Press lyon. Essential thrombocythaemia, p39.
11. MICHIELS JJ. (1997). Erythromelalgia and thrombocythaemia: a disease of platelet prostaglandin metabolism. Semin Thromb Hemost, 23: 335-338.
12. PEARSON TC, WETHERLEY-MEIN G. (1978). Vascular occlusive episodes and venous haematocritin primary proliferative polycythemia. Lancet, ii: 1219-1222.
13. ROZMAN C, GIRALT M, FELIU E. (1991). Life expectancy of patients with chronic non-leukemic myeloproliferative disorders. Cancer, 67: 2658-2663.
14. RUGGERI M, FINAZZI G, TOSETTO A. (1998). No treatment for low-risk thrombocythaemia: results from A prospective study. Br J Haematol, 103: 772-777.
15. VAN GENDEREN PJ, MICHIELS JJ. (1997). Erythromelalgia: a pathognomonic microvascular thrombic complication in essential thrombocythaemia and polycythemia vera. Semin Thromb Hemost, 23: 357-363.
16. VAN GENDEREN PJ, MULDER PGH, VAN DE MOESDIJK D, MICHIELS JJ. (1997). Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin. Br J haematol, 97: 179-184.
17. WATSON KV, KEY N. (1993). Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors. Br J Haematol, 83: 198-203.